Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai-Uwe Jarr

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
European Heart Journal|September 9, 2025
The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibitionKai-Uwe Jarr, Lingfeng Luo, Nicholas J Leeper
Circulation|March 2, 2026
Microplastics and Nanoplastics: A New Perspective in Cardiovascular PreventionKai-Uwe Jarr, Annette Peters, Nicholas J Leeper
Mediators of Inflammation|August 5, 2014
Inter- not intraindividual differences in sTWEAK levels predict functional deterioration and mortality in patients with dilated cardiomyopathyKai-Uwe Jarr, Manfred Nelles, Hugo A Katus, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2022
2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) AxisKai-Uwe Jarr, Yoko Kojima, Irving L Weissman, et al.
The Journal of Invasive Cardiology|November 16, 2016
Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve SystemKai-Uwe Jarr, Florian Leuschner, Benjamin Meder, et al.
Circulation|July 21, 2025
Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human AtherosclerosisKai-Uwe Jarr, Kaylin C A Palm, Gerard Pasterkamp, et al.
European Heart Journal|June 27, 2025
Smooth muscle cells in atherosclerosis: essential but overlooked translational perspectivesPascal Azar, Kai-Uwe Jarr, Delphine Gomez, et al.
Mediators of Inflammation|April 3, 2014
TNF-like weak inducer of apoptosis aggravates left ventricular dysfunction after myocardial infarction in miceKai-Uwe Jarr, Sabine Eschricht, Linda C Burkly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2019
Nanoparticle Therapy for Vascular DiseasesAlyssa M Flores, Jianqin Ye, Kai-Uwe Jarr, et al.
Journal of Molecular and Cellular Cardiology|June 3, 2015
Heat-shock-protein 90 protects from downregulation of HIF-1α in calcineurin-induced myocardial hypertrophySabine Eschricht, Kai-Uwe Jarr, Christian Kuhn, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
European Heart Journal|September 9, 2025
The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibitionKai-Uwe Jarr, Lingfeng Luo, Nicholas J Leeper
Circulation|March 2, 2026
Microplastics and Nanoplastics: A New Perspective in Cardiovascular PreventionKai-Uwe Jarr, Annette Peters, Nicholas J Leeper
Mediators of Inflammation|August 5, 2014
Inter- not intraindividual differences in sTWEAK levels predict functional deterioration and mortality in patients with dilated cardiomyopathyKai-Uwe Jarr, Manfred Nelles, Hugo A Katus, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2022
2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) AxisKai-Uwe Jarr, Yoko Kojima, Irving L Weissman, et al.
The Journal of Invasive Cardiology|November 16, 2016
Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve SystemKai-Uwe Jarr, Florian Leuschner, Benjamin Meder, et al.
Circulation|July 21, 2025
Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human AtherosclerosisKai-Uwe Jarr, Kaylin C A Palm, Gerard Pasterkamp, et al.
European Heart Journal|June 27, 2025
Smooth muscle cells in atherosclerosis: essential but overlooked translational perspectivesPascal Azar, Kai-Uwe Jarr, Delphine Gomez, et al.
Mediators of Inflammation|April 3, 2014
TNF-like weak inducer of apoptosis aggravates left ventricular dysfunction after myocardial infarction in miceKai-Uwe Jarr, Sabine Eschricht, Linda C Burkly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2019
Nanoparticle Therapy for Vascular DiseasesAlyssa M Flores, Jianqin Ye, Kai-Uwe Jarr, et al.
Journal of Molecular and Cellular Cardiology|June 3, 2015
Heat-shock-protein 90 protects from downregulation of HIF-1α in calcineurin-induced myocardial hypertrophySabine Eschricht, Kai-Uwe Jarr, Christian Kuhn, et al.
Pageof 3